Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amgen, Inc. (AMGN) vs Home Depot Inc (HD) Price & Performance

Amgen, Inc.
Home Depot Inc

Price performance

Price movement over the last 24 hours

Key statistics

Amgen, Inc. vs Home Depot Inc — how do they compare? Amgen, Inc. trades at $363.66 (market cap $196.12B), while Home Depot Inc trades at $343.81 (market cap $342.31B). The key difference: Home Depot Inc is the larger of the two by market cap, and Amgen, Inc. pays the higher dividend (2.77%). Which is the better fit depends on your goals.

AMGNHD
Market Cap
$196.12B$342.31B
Sector
HealthConsumer Cyclical
52-Week High
$388.16$423.42
52-Week Low
$271.18$297.51
Enterprise Value
$241.41B$403.87B
Dividend Yield
2.77%2.71%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amgen, Inc.

AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.

The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.

Home Depot Inc

Home Depot (HD) trades at $343.30, up 1.35% on the day, with mixed technical signals showing a bearish overall trend but bullish moving averages. The company reported $159.51B in revenue for 2025 with a net income margin of 8.41%, though earnings per share missed expectations in Q3 2025 but beat in subsequent quarters. Recent news highlights institutional trading activity and concerns over weak big-ticket demand and rising mortgage rates impacting home improvement stocks.

The outlook remains cautious with a consensus price target of $370.59 suggesting upside potential, but risks include margin pressure from investments and housing market sensitivity. Long-term growth relies on professional customer demand and housing tailwinds, though near-term volatility may persist due to economic conditions.

Returns comparison

Trailing returns across standard periods

About Amgen, Inc.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Read more on AMGN

About Home Depot Inc

Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.

Read more on HD